Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma

Author： Daud Adil Soon Christopher Dummer Reinhard Eggermont Alexander MM Hwu Wen-Jen Grob Jean Jacques Garbe Claus Hauschild Axel

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.12, Iss.8, 2012-08, pp. : 1087-1099

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients

By Fekkes D. Bannink M. Kruit W. H. J. Van Gool A. R. Mulder P. G. H. Sleijfer S. Eggermont A. M. M. Stoter G.

Amino Acids, Vol. 32, Iss. 1, 2007-01 ,pp. : 121-126

Springer Publishing Company

Access to resources Recommend Favorite

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Alpha Interferon for Treating Prostate Cancer

By Morales

Enzyme and Microbial Technology, Vol. 20, Iss. 3, 1997-02 ,pp. : 239-239

Elsevier

Access to resources Recommend Favorite

Participation of Interferon-Alpha in Regulation of Apoptosis

By Bazhanova E.

Journal of Evolutionary Biochemistry and Physiology, Vol. 41, Iss. 2, 2005-03 ,pp. : 127-133

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Study of Toxicity Effect of Pegylated Nanoliposomal Artemisinin on Breast Cancer Cell Line

By Dadgar Neda Alavi Seyed Esfahani Maedeh Akbarzadeh Azim

Indian Journal of Clinical Biochemistry, Vol. 28, Iss. 4, 2013-10 ,pp. : 410-412

Springer Publishing Company

Access to resources Recommend Favorite